Index RUT P/E - EPS (ttm) -1.03 Insider Own 5.03% Shs Outstand 114.96M Perf Week -2.76%
Market Cap 3.33B Forward P/E 27.31 EPS next Y 1.06 Insider Trans -4.32% Shs Float 109.18M Perf Month 20.44%
Income -112.21M PEG - EPS next Q 0.16 Inst Own 107.03% Short Float / Ratio 7.57% / 8.60 Perf Quarter 10.93%
Sales 1.79B P/S 1.86 EPS this Y -17.28% Inst Trans 5.47% Short Interest 8.26M Perf Half Y -6.77%
Book/sh 9.68 P/B 2.99 EPS next Y 34.79% ROA -4.11% Target Price 45.30 Perf Year 0.49%
Cash/sh 1.81 P/C 16.01 EPS next 5Y 30.00% ROE -9.32% 52W Range 23.33 - 36.70 Perf YTD 3.03%
Dividend 0.26 P/FCF 59.97 EPS past 5Y 26.68% ROI -5.87% 52W High -21.17% Beta 1.44
Dividend % 0.90% Quick Ratio 1.04 Sales past 5Y 27.10% Gross Margin 18.23% 52W Low 24.00% ATR 1.00
Employees 5100 Current Ratio 1.04 Sales Q/Q 44.93% Oper. Margin 1.09% RSI (14) 55.58 Volatility 3.66% 3.58%
Optionable Yes Debt/Eq 0.76 EPS Q/Q -1481.78% Profit Margin -6.27% Rel Volume 0.95 Prev Close 27.80
Shortable Yes LT Debt/Eq 0.74 Earnings Nov 02 AMC Payout - Avg Volume 960.22K Price 28.93
Recom 1.18 SMA20 1.72% SMA50 5.98% SMA200 -3.16% Volume 916,091 Change 4.06%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-16-23 Initiated UBS
Buy
$46
Apr-12-23 Initiated Stephens
Overweight
$40
Nov-01-22 Initiated Truist
Hold
$33
Jul-29-22 Initiated RBC Capital Mkts
Outperform
$40
Mar-30-22 Initiated Guggenheim
Buy
$43
Nov-18-21 Upgrade JP Morgan
Neutral → Overweight
$26 → $37
Apr-29-21 Resumed JP Morgan
Neutral
$23
Jan-07-21 Initiated BTIG Research
Buy
$20
Jul-06-20 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
Jun-05-20 Downgrade Goldman
Buy → Neutral
$13 → $8
Jun-02-20 Downgrade Cantor Fitzgerald
Overweight → Neutral
$9 → $8
Oct-05-18 Resumed Leerink Partners
Outperform
$35
Jun-04-18 Initiated Piper Jaffray
Overweight
$30
Apr-24-18 Resumed JP Morgan
Neutral
$17
Sep-20-17 Initiated KeyBanc Capital Mkts
Overweight
$23
Jun-02-17 Initiated Robert W. Baird
Outperform
$30
Mar-14-17 Initiated Oppenheimer
Outperform
Jan-13-17 Upgrade Wells Fargo
Market Perform → Outperform
Oct-28-16 Resumed JP Morgan
Overweight
Aug-05-16 Reiterated FBR Capital
Outperform
$24 → $26
Show Previous Ratings
Nov-20-23 09:55AM
Nov-05-23 05:18PM
Nov-03-23 05:30AM
Nov-02-23 07:09PM
06:50PM
05:49PM
Loading…
05:49PM
(Associated Press Finance)
04:10PM
Oct-26-23 07:52AM
Oct-25-23 07:30PM
Oct-23-23 09:55AM
Oct-10-23 05:30PM
09:15AM
Oct-06-23 09:55AM
Oct-05-23 12:00PM
Aug-24-23 05:20PM
05:00PM
Loading…
Aug-08-23 05:00PM
Aug-04-23 09:51AM
Aug-02-23 10:30PM
07:35PM
06:32PM
04:10PM
Jul-26-23 04:42PM
Jul-13-23 04:15PM
Jul-11-23 09:00AM
Jul-03-23 09:51AM
May-22-23 07:50AM
May-09-23 07:30AM
May-05-23 12:40PM
May-04-23 11:47AM
(Thomson Reuters StreetEvents)
02:00AM
06:45PM
Loading…
May-03-23 06:45PM
05:34PM
04:10PM
Apr-19-23 04:10PM
Apr-18-23 01:10PM
Apr-17-23 04:45PM
Mar-30-23 11:10AM
Mar-29-23 04:10PM
Mar-27-23 07:29AM
Mar-08-23 06:30AM
Mar-03-23 08:00AM
Feb-24-23 05:44AM
Feb-23-23 01:10PM
Feb-22-23 10:00PM
06:55PM
04:10PM
Feb-09-23 08:15AM
Feb-02-23 05:18AM
Jan-31-23 05:00PM
Jan-23-23 12:20PM
(American City Business Journals)
11:58AM
Jan-03-23 05:37AM
Dec-13-22 05:36AM
Nov-29-22 04:15PM
Nov-18-22 03:01PM
11:21AM
06:50AM
Nov-17-22 06:37PM
(American City Business Journals)
04:45PM
04:01PM
Nov-16-22 06:42PM
Nov-15-22 09:49AM
Nov-04-22 09:35AM
Nov-02-22 10:30PM
07:05PM
04:10PM
Oct-20-22 09:40AM
Oct-17-22 12:11PM
Oct-14-22 09:18AM
Oct-04-22 09:40AM
Sep-30-22 07:30AM
Sep-22-22 09:25AM
Sep-09-22 05:00AM
Sep-06-22 05:22PM
(American City Business Journals)
04:15PM
Aug-10-22 12:00PM
11:55AM
Aug-08-22 09:55AM
Aug-05-22 07:42AM
Aug-03-22 02:48PM
08:10AM
(Investor's Business Daily)
Aug-02-22 11:30PM
06:45PM
04:55PM
(Investor's Business Daily)
04:10PM
Aug-01-22 04:15PM
Jul-28-22 10:03AM
Jul-26-22 03:50PM
(American City Business Journals)
10:01AM
Jul-20-22 08:50AM
Jul-15-22 05:30PM
08:00AM
Jul-14-22 12:00PM
09:40AM
Jul-12-22 09:33AM
(Investor's Business Daily) -6.85%
Jul-11-22 09:49AM
(Investor's Business Daily) -5.80%
Jul-08-22 09:52AM
(Investor's Business Daily)
Jul-07-22 09:55AM
(Investor's Business Daily)
Jul-06-22 04:05PM
(Investor's Business Daily)
02:15PM
(Investor's Business Daily)
Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
McCarthy Daniel Joseph PRESIDENT Nov 15 Option Exercise 10.65 3,000 31,950 201,333 Nov 20 08:01 AM McCarthy Daniel Joseph PRESIDENT Nov 15 Sale 30.00 11,000 330,000 198,333 Nov 20 08:01 AM Rafferty Emily Ann Chief Operating Officer Aug 15 Sale 28.05 7,900 221,595 70,897 Aug 17 04:35 PM Blackley Seth Chief Executive Officer Jun 28 Option Exercise 3.84 33,011 126,762 816,022 Jun 30 04:27 PM Blackley Seth Chief Executive Officer Jun 28 Sale 30.78 33,011 1,016,022 783,011 Jun 30 04:27 PM Blackley Seth Chief Executive Officer Jun 16 Option Exercise 3.84 2,098 8,056 785,109 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 16 Sale 30.16 2,098 63,276 783,011 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 15 Option Exercise 3.84 75,931 291,575 858,942 Jun 20 04:36 PM Blackley Seth Chief Executive Officer Jun 15 Sale 30.20 75,931 2,293,116 783,011 Jun 20 04:36 PM Scott Cheryl Director Jun 14 Sale 30.01 2,365 70,974 53,788 Jun 16 04:38 PM DUFFY MARY BRIDGET Director Jun 13 Sale 30.97 5,564 172,317 49,935 Jun 15 04:24 PM Holder Diane Director Jun 12 Sale 31.26 12,000 375,120 60,140 Jun 14 05:04 PM McCarthy Daniel Joseph PRESIDENT Jun 12 Sale 31.44 1,000 31,440 206,333 Jun 14 05:01 PM WILLIAMS FRANK J Director Jun 01 Option Exercise 9.68 110,000 1,064,896 929,812 Jun 05 04:23 PM WILLIAMS FRANK J Director Jun 01 Sale 29.52 110,000 3,247,108 819,812 Jun 05 04:23 PM WILLIAMS FRANK J Director May 01 Option Exercise 6.87 110,000 755,700 929,812 May 03 04:24 PM WILLIAMS FRANK J Director May 01 Sale 36.29 110,000 3,991,900 819,812 May 03 04:24 PM WILLIAMS FRANK J Director Apr 03 Option Exercise 6.87 110,000 755,700 929,812 Apr 05 04:43 PM WILLIAMS FRANK J Director Apr 03 Sale 31.83 110,000 3,501,348 819,812 Apr 05 04:43 PM WILLIAMS FRANK J Director Mar 07 Sale 34.62 116,311 4,026,687 819,812 Mar 07 06:04 PM Blackley Seth Chief Executive Officer Mar 07 Sale 34.62 95,055 3,290,804 783,011 Mar 07 06:06 PM WILLIAMS FRANK J Director Mar 06 Sale 34.42 90,356 3,109,744 936,123 Mar 07 06:04 PM Blackley Seth Chief Executive Officer Mar 06 Sale 34.42 73,928 2,544,351 878,066 Mar 07 06:06 PM WILLIAMS FRANK J Director Mar 03 Option Exercise 0.00 400,000 0 1,026,479 Mar 07 06:04 PM Blackley Seth Chief Executive Officer Mar 03 Option Exercise 0.00 360,000 0 951,994 Mar 07 06:06 PM WILLIAMS FRANK J Director Mar 01 Option Exercise 6.62 110,000 728,248 727,419 Mar 02 05:07 PM WILLIAMS FRANK J Director Mar 01 Sale 34.98 110,000 3,847,709 626,479 Mar 02 05:07 PM WILLIAMS FRANK J Director Feb 01 Option Exercise 3.84 110,000 422,400 736,479 Feb 03 05:05 PM WILLIAMS FRANK J Director Feb 01 Sale 32.16 110,000 3,537,265 626,479 Feb 03 05:05 PM WILLIAMS FRANK J Director Jan 03 Option Exercise 3.84 110,000 422,400 736,479 Jan 05 04:58 PM WILLIAMS FRANK J Director Jan 03 Sale 27.15 110,000 2,986,690 626,479 Jan 05 04:58 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
